NASDAQ

Apyx Medical Corporation (APYX)

481 Thanks from members

Apyx Medical Corporation (APYX) displays mixed financial and market sentiment, backed by strong second-quarter 2026 revenue growth in Surgical Aesthetics and expanding product platforms, balanced by neutral alternative data indicators and conservative stock performance.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →